Beyond Antibodies: Influenza Vaccine Induced T-Cell Response in Hematological Malignancy— Commentary on Insights From Hall et al - Takeaways - MDSpire

Beyond Antibodies: Influenza Vaccine Induced T-Cell Response in Hematological Malignancy— Commentary on Insights From Hall et al

  • By

  • Katja M Sauer

  • Eloísa Felipe Fumero

  • Oliver A Cornely

  • Anna Nordlander

  • Sigrun Einarsdottir

  • Sibylle C Mellinghoff

  • February 10, 2026

  • 0 min

Share

  • 1

    Hall et al's study reveals no significant differences in immune responses between adjuvanted and standard-dose influenza vaccines in hematological malignancy patients.

  • 2

    Patients with hematological malignancies face significantly higher mortality rates from influenza, highlighting the importance of understanding their vaccine responses.

  • 3

    The study demonstrates preserved influenza-specific T-cell immunity in patients, despite blunted B-cell responses, indicating a dissociation between humoral and cellular immunity.

  • 4

    T-cell responses may predict protection against influenza infection more accurately than antibody titers, underscoring the need for T-cell analyses in future studies.

  • 5

    Influenza vaccination is generally well tolerated in hematological malignancy patients, yet uptake remains low, necessitating improved vaccination strategies.

Original Source(s)

Beyond Antibodies: Influenza Vaccine Induced T-Cell Response in Hematological Malignancy— Commentary on Insights From Hall et al

  • by Katja M Sauer, Eloísa Felipe Fumero, Oliver A Cornely, Anna Nordlander, Sigrun Einarsdottir, Sibylle C Mellinghoff

  • February 10, 2026

Related Content

Parenteral neonatal priming followed by heterologous mucosal booster favors IgM+ memory B cell induction over systemic plasma cell differentiation

Measles Wild-Type Virus Detection Through Wastewater Surveillance in Sandoval County, New Mexico

HPV Vaccine Uptake Varied Widely Across US States

Analysis of more than 16,000 US adolescents found substantial variation in HPV vaccination uptake both across and within census regions